Penumbra (PEN) Cash & Equivalents (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.10% |
| Dec 31, 2025 | -41.78% |
| Sep 30, 2025 | -23.88% |
| Jun 30, 2025 | 12.16% |
| Mar 31, 2025 | 15.92% |
| Dec 31, 2024 | 15.66% |
| Sep 30, 2024 | -2.72% |
| Jun 30, 2024 | 29.23% |
| Mar 31, 2024 | 33.21% |
| Dec 31, 2023 | 66.23% |
| Sep 30, 2023 | -11.75% |
| Jun 30, 2023 | 20.57% |
| Mar 31, 2023 | 35.54% |
| Dec 31, 2022 | 27.38% |
| Sep 30, 2022 | -5.82% |
| Jun 30, 2022 | -14.57% |
| Mar 31, 2022 | 14.79% |
| Dec 31, 2021 | -10.43% |
| Mar 31, 2021 | -20.15% |
| Dec 31, 2020 | -13.04% |
| Sep 30, 2020 | -40.38% |
| Jun 30, 2020 | 85.47% |
| Mar 31, 2020 | -0.44% |
| Dec 31, 2019 | -34.77% |
| Sep 30, 2019 | 44.42% |
| Jun 30, 2019 | 13.87% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 42.12% |
| Sep 30, 2018 | -20.04% |
| Jun 30, 2018 | 17.91% |
| Mar 31, 2018 | 0.00% |
| Dec 31, 2017 | -22.83% |
| Sep 30, 2017 | -14.31% |
| Jun 30, 2017 | -29.99% |
| Mar 31, 2017 | 726.41% |
| Dec 31, 2016 | -16.52% |
| Sep 30, 2016 | 13.96% |
| Jun 30, 2016 | -20.97% |
| Mar 31, 2016 | -9.93% |
| Dec 31, 2015 | -87.71% |
| Sep 30, 2015 | 332.75% |
| Jun 30, 2015 | 352.09% |
| Mar 31, 2015 | 147.17% |
| Dec 31, 2014 | -59.82% |